IRIS UniCatt

Mazzone, Elena Stacy
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.234
NA - Nord America 1.783
AS - Asia 1.310
SA - Sud America 238
Continente sconosciuto - Info sul continente non disponibili 43
AF - Africa 37
OC - Oceania 1
Totale 5.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.713
DE - Germania 1.083
SG - Singapore 603
NL - Olanda 371
IT - Italia 304
CN - Cina 300
BR - Brasile 191
VN - Vietnam 96
FR - Francia 93
SE - Svezia 90
GB - Regno Unito 63
IE - Irlanda 54
JP - Giappone 46
IN - India 45
HK - Hong Kong 41
ID - Indonesia 40
CA - Canada 37
FI - Finlandia 33
RU - Federazione Russa 33
PL - Polonia 28
BD - Bangladesh 26
KR - Corea 24
TR - Turchia 22
ES - Italia 17
AR - Argentina 16
PK - Pakistan 13
MX - Messico 11
ZA - Sudafrica 11
IQ - Iraq 9
PE - Perù 9
CO - Colombia 8
EC - Ecuador 8
AT - Austria 7
UA - Ucraina 7
IL - Israele 6
LT - Lituania 6
PH - Filippine 6
SA - Arabia Saudita 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
DZ - Algeria 5
EG - Egitto 5
JM - Giamaica 5
UZ - Uzbekistan 5
CH - Svizzera 4
IR - Iran 4
PA - Panama 4
TN - Tunisia 4
GT - Guatemala 3
LV - Lettonia 3
MA - Marocco 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HR - Croazia 2
KZ - Kazakistan 2
NG - Nigeria 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
TT - Trinidad e Tobago 1
Totale 5.603
Salva come PNG Salva come JPEG
Città #
Singapore 354
Amsterdam 350
Frankfurt am Main 341
Ashburn 249
San Jose 191
Los Angeles 186
Chandler 108
New York 99
Hefei 77
Dallas 52
Beijing 50
Rome 50
Tukwila 49
Dublin 45
Tokyo 45
Lauterbourg 39
Hong Kong 38
Jakarta 38
Munich 38
Ho Chi Minh City 37
Chicago 33
Milan 32
Hanoi 27
Santa Clara 27
Seoul 24
Council Bluffs 22
São Paulo 21
Kent 20
Warsaw 20
Boston 17
Denver 17
Helsinki 17
Atlanta 16
Houston 15
Moscow 15
Palermo 15
London 14
Nuremberg 14
Boardman 13
Chennai 13
Turku 13
Toronto 12
Poplar 11
Stockholm 11
Buffalo 10
Düsseldorf 10
Marseille 10
Pune 10
Brooklyn 9
Lima 9
Orem 9
Princeton 9
San Francisco 9
Johannesburg 8
Phoenix 8
Ankara 7
Columbus 7
Florence 7
Manchester 7
Montreal 7
San Mateo 7
Secaucus 7
Falkenstein 6
Hangzhou 6
Istanbul 6
The Dalles 6
Wilmington 6
Brasília 5
City of London 5
Curitiba 5
Mexico City 5
Naples 5
Shenzhen 5
Tashkent 5
Turin 5
Washington 5
Ancona 4
Calgary 4
Edinburgh 4
Fairfield 4
Haiphong 4
Kiel 4
Las Vegas 4
Mumbai 4
New Delhi 4
Philadelphia 4
Quito 4
Rio de Janeiro 4
Shanghai 4
Sofia 4
Bern 3
Bremen 3
Brno 3
Bucaramanga 3
Busto Arsizio 3
Duque de Caxias 3
Faisalabad 3
Guatemala City 3
Harrisburg 3
Hyderabad 3
Totale 3.186
Salva come PNG Salva come JPEG
Nome #
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 1.044
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 734
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 287
Performance of Upper Limb module for Duchenne muscular dystrophy 257
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 160
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 159
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 150
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 142
Our Experience on Temporal Bone Fractures: Retrospective Analysis of 141 Cases 140
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 132
Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report 130
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 130
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 121
Sleep disorders in spinal muscular atrophy 119
Revised upper limb module for spinal muscular atrophy: Development of a new module 117
Clinical Variability in Spinal Muscular Atrophy Type III. 115
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 113
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 110
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 106
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 102
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA) 100
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 91
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 91
Old measures and new scores in spinal muscular atrophy patients 90
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 85
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 78
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 77
First international workshop on rehabilitation management and clinical outcome measures for spinal muscular atrophy 73
Early neurodevelopmental assessment in Duchenne muscular dystrophy 71
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients 68
Assessing upper limb function in nonambulant SMA patients: Development of a new module 65
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool 59
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability 58
Daily salbutamol in young patients with SMA type II 57
Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM 55
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy 54
Correction: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-Month changes 52
Reliability of the North Star Ambulatory Assessment in a multicentric setting 47
Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale 7
Totale 5.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202282 0 0 0 19 4 6 3 10 4 6 18 12
2022/2023359 19 30 26 44 30 59 17 34 51 12 20 17
2023/2024467 22 83 12 23 15 87 40 43 11 21 50 60
2024/2025852 22 15 82 25 60 53 47 34 82 69 209 154
2025/20263.615 267 68 177 321 470 1.419 339 98 130 118 122 86
2026/2027258 200 58 0 0 0 0 0 0 0 0 0 0
Totale 5.646